title: An open-label trial of adjunctive oxcarbazepine for bipolar disorder.
authors.forename: Charles R
authors.initials: CR
authors.lastname: Conway
authors.forename: John T
authors.initials: JT
authors.lastname: Chibnall
authors.forename: Leigh Anne
authors.initials: LA
authors.lastname: Nelson
authors.forename: J Michael
authors.initials: JM
authors.lastname: McGuire
authors.forename: Praveen F
authors.initials: PF
authors.lastname: Abraham
authors.forename: Vadim Y
authors.initials: VY
authors.lastname: Baram
authors.forename: George T
authors.initials: GT
authors.lastname: Grossberg
authors.forename: Bernard J
authors.initials: BJ
authors.lastname: Carroll
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000078330:Oxcarbazepine; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D000928:Antidepressive Agents; D018692:Antimanic Agents; D002220:Carbamazepine; D000078330:Oxcarbazepine